Corrigendum to “Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study” [Bone 160 (2022) 116416]
Bone（2022）
关键词
postmenopausal osteoporosis,daily teriparatide,bisphosphonate,bone,high-dose
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要